X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (438) 438
male (325) 325
animals (304) 304
female (252) 252
vinca alkaloids - administration & dosage (247) 247
middle aged (182) 182
adult (166) 166
vinca alkaloids - pharmacology (162) 162
index medicus (159) 159
aged (150) 150
pharmacology & pharmacy (150) 150
vinca alkaloids - therapeutic use (150) 150
vinca alkaloids (139) 139
oncology (133) 133
rats (125) 125
mice (96) 96
cancer (80) 80
administration, oral (79) 79
vinpocetine (79) 79
chemotherapy (71) 71
treatment outcome (70) 70
vinblastine - analogs & derivatives (67) 67
vinca alkaloids - adverse effects (66) 66
dose-response relationship, drug (64) 64
vinblastine - administration & dosage (60) 60
injections, intravenous (58) 58
vincristine (58) 58
pharmacokinetics (56) 56
vinca alkaloids - pharmacokinetics (54) 54
antineoplastic combined chemotherapy protocols - therapeutic use (53) 53
antineoplastic agents - administration & dosage (52) 52
time factors (52) 52
vinca alkaloid (50) 50
neoplasms - drug therapy (48) 48
vinorelbine (48) 48
vinblastine (46) 46
antineoplastic agents, phytogenic - administration & dosage (45) 45
cerebrovascular circulation - drug effects (43) 43
antineoplastic agents - adverse effects (42) 42
drug administration schedule (41) 41
infusions, intravenous (41) 41
vasodilator agents - administration & dosage (39) 39
antineoplastic agents - therapeutic use (38) 38
research (37) 37
vinblastine - therapeutic use (36) 36
cerebrovascular disorders - drug therapy (34) 34
vincristine - administration & dosage (34) 34
biological availability (33) 33
kinetics (33) 33
rats, wistar (33) 33
drug therapy, combination (32) 32
vasodilator agents - therapeutic use (32) 32
adolescent (31) 31
vinca alkaloids - metabolism (31) 31
alkaloids (30) 30
breast neoplasms - drug therapy (30) 30
dogs (30) 30
in-vitro (29) 29
rats, sprague-dawley (29) 29
vincamine - administration & dosage (29) 29
drugs (28) 28
lung neoplasms - drug therapy (28) 28
vinblastine - pharmacokinetics (28) 28
antineoplastic agents (27) 27
brain - drug effects (27) 27
clinical trials as topic (27) 27
medicine & public health (27) 27
neurosciences (27) 27
vinblastine - adverse effects (27) 27
aged, 80 and over (26) 26
antineoplastic agents, phytogenic - therapeutic use (26) 26
drug therapy (26) 26
paclitaxel (26) 26
vinca alkaloids - blood (26) 26
vinca alkaloids - chemistry (26) 26
antineoplastic agents - pharmacology (25) 25
brain - metabolism (25) 25
care and treatment (25) 25
disease models, animal (25) 25
apoptosis (24) 24
biochemistry & molecular biology (24) 24
tubulin (24) 24
vasodilator agents - pharmacology (24) 24
vinblastine - pharmacology (24) 24
antineoplastic agents, phytogenic - adverse effects (23) 23
drug evaluation (23) 23
half-life (23) 23
in-vivo (23) 23
solubility (23) 23
antineoplastic agents, phytogenic - pharmacokinetics (22) 22
dosage and administration (22) 22
neuroprotective agents - administration & dosage (22) 22
tissue distribution (22) 22
antineoplastic agents, phytogenic - pharmacology (21) 21
cell line, tumor (21) 21
drug delivery systems (21) 21
follow-up studies (21) 21
navelbine (21) 21
rat (21) 21
vinflunine (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (547) 547
Russian (65) 65
French (23) 23
Japanese (16) 16
German (15) 15
Italian (12) 12
Hungarian (11) 11
Spanish (5) 5
Chinese (4) 4
Polish (4) 4
Portuguese (2) 2
Bulgarian (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 35, pp. 4400 - 4406
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 2011, Volume 77, Issue 1, pp. 43 - 55
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 4/2018, Volume 26, Issue 4, pp. 1019 - 1028
Over half of all cancer patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy experience chemotherapy-induced peripheral neuropathy... 
Pain Medicine | Nursing | Rehabilitation Medicine | Exercise | Medicine & Public Health | Nursing Research | Oncology | CIPN | Neuropathy | MANAGEMENT | PREVENTION | PREVALENCE | CANCER SURVIVORS | PAIN | ONCOLOGY | PREDICTORS | CLINICAL-TRIALS | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | PHYSICAL-ACTIVITY | QUALITY-OF-LIFE | OUTCOMES | Exercise Therapy - methods | Peripheral Nervous System Diseases - chemically induced | Humans | Middle Aged | Vinca Alkaloids - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Peripheral Nervous System Diseases - therapy | Male | Peripheral Nervous System Diseases - physiopathology | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Taxoids - administration & dosage | Organoplatinum Compounds - administration & dosage | Vinca Alkaloids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Bridged-Ring Compounds - adverse effects | Female | Neoplasm Staging | Neoplasms - pathology | Bridged-Ring Compounds - administration & dosage | Organoplatinum Compounds - adverse effects | Taxoids - adverse effects | Alkaloids | Chemotherapy | Health aspects | Analysis | Mortality | Cancer | Clinical trials | Breast cancer | Peripheral neuropathy | Index Medicus | exercise | neuropathy
Journal Article
Journal of Clinical Pharmacology, ISSN 0091-2700, 2009, Volume 49, Issue 12, pp. 1467 - 1476
Journal Article
Journal Article